Stock Events

Stock Events

Cardiogenics 

$0.000100
2
+$0.00+0%Thursday 17:57

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0001
52W Low
0.0001
Volume
3,066
Avg. Volume
296
Mkt Cap
9,286.7
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Jan 31Expected
Q2 2014
Q3 2014
Q4 2014
Q1 2015
Q2 2015
Q3 2015
Q4 2015
-0.02
-0.01
-0.01
0
Expected EPS
N/A
Actual EPS
-0.0011

Financials

-Profit Margin
Unprofitable
2012
2013
2014
2015
0Revenue
-1.92MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories manufactures medical devices and diagnostics products, competing in the cardiovascular and diagnostics sectors similar to Cardiogenics.
Medtronic
MDT
Mkt Cap123.49B
Medtronic plc specializes in medical technologies, services, and solutions, including those for cardiac and vascular diseases, directly competing with Cardiogenics' offerings.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, including cardiac rhythm management.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson engages in the research and development, manufacture and sale of a broad range of products in the healthcare field, including cardiovascular devices.
Stryker
SYK
Mkt Cap111.95B
Stryker Corporation specializes in medical technologies, including surgical equipment and neurovascular products, competing in the broader medical device market.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, indirectly competing by advancing minimally invasive surgery, including cardiac procedures.
Edwards Lifesciences
EW
Mkt Cap53.03B
Edwards Lifesciences Corporation specializes in heart valve therapy and critical care, directly competing in the cardiovascular market.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet Holdings, Inc. manufactures musculoskeletal healthcare products but also provides surgical solutions that can overlap with cardiac surgical aids.

About

CardioGenics Holdings Inc. focuses on the creation and global distribution of diagnostic testing solutions within the in vitro diagnostics (IVD) sector, serving markets across the United States, Canada, Europe, and other international regions. A key offering is the QL Care Analyzer, an automated, self-contained, and portable point-of-care (POC) immunoassay device. This analyzer utilizes a unique, patented self-metering cartridge to perform immunoassay evaluations directly at the point of care. The company also provides a range of immunoassay panels specifically engineered to detect cardiac biomarkers in blood, which is vital for identifying heart attacks. Additionally, CardioGenics supplies paramagnetic beads, serving as crucial solid supports in heterogeneous immunoassay procedures for both clinical and research institutions. Established in 1997, the company was initially known as Jag Media Holdings, Inc. before officially changing its name to CardioGenics Holdings Inc. in 2009. Its corporate headquarters are situated in Mississauga, Canada.
Show More
CEO
Yahia Abdul Gawad
Employees
4
Country
United States
ISIN
US14160X2036

Listings

OTC Link
US
CGNH

0 Comments

Share your thoughts

FAQs

What is Cardiogenics stock price today?▼
The current price of CGNH is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Cardiogenics stock price performance more closely on the chart.
What is Cardiogenics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Cardiogenics stocks are traded under the ticker CGNH.
Is Cardiogenics stock price growing?▼
CGNH stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Cardiogenics has showed a +0% increase.
What is Cardiogenics market cap?▼
Today Cardiogenics has the market capitalization of 9,286.7
What were Cardiogenics earnings last quarter?▼
CGNH earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cardiogenics revenue for the last year?▼
Cardiogenics revenue for the last year amounts to 0 USD.
What is Cardiogenics net income for the last year?▼
CGNH net income for the last year is -1.92M USD.
How many employees does Cardiogenics have?▼
As of November 2, 2026, the company has 4 employees.
In which sector is Cardiogenics located?▼
Cardiogenics operates in the Health & Wellness sector.
When did Cardiogenics complete a stock split?▼
The last stock split for Cardiogenics was on June 22, 2010 with a ratio of 1:10.
Where is Cardiogenics headquartered?▼
Cardiogenics is headquartered in Mississauga, United States.